| ACC | Acetyl CoA carboxylase |
| AKAP4 | A-kinase anchoring protein 4 |
| AMP | Adenosine monophosphate |
| AMPK | 5′ AMP activated protein kinase |
| ATP | Adenosine triphosphate |
| BAGE | B melanoma antigen |
| CTA | Cancer testis antigen |
| DDIT4/REDD1 | DNA Damage Inducible Transcript 4/Regulated in DNA Damage 1 |
| EMT | Epithelial mesenchymal transition |
| ER | Estrogen receptor |
| ERK | Extracellular signal-regulated kinase |
| ETC | Electron transport chain |
| HER2 | Human epidermal growth factor receptor 2 |
| IGF1 | Insulin-like growth factor 1 |
| IRS1 | Insulin receptor substrate 1 |
| MAGE | Melanoma antigen |
| MAPK | Mitogen activated protein kinase |
| MATE1/2 | Multidrug and toxin extrusion protein-1 and 2 |
| mTOR | mammalian target of rapamycin |
| NF-κB | Nuclear factor kappa-B |
| OCT1/2/3 | Organic cation transporters 1, 2 and 3 |
| PAI-1 | Plasminogen activator inhibitor 1 |
| PI3K | Phosphoinositide 3-kinase |
| PMAT | Plasma membrane monoamine transporter |
| PR | Progesterone receptor |
| PTP | Permeability transition pore |
| SP17 | Sperm protein 17 |
| STAT3 | Signal transducer and activator of transcription 3 |
| TNBC | Triple negative breast cancer |
| TNFα | Tumor necrosis factor alpha |
| TSC2 | Tuberous sclerosis 2 |
| UAP1 | UDP-N-acetylglucosamine pyrophosphorylase 1 |
| uPA | Urokinase-type plasminogen activator |
| UPR | Unfolded Protein Response |
| WHO | World Health Organization |